ライフサイエンスコーパス: carotid endarterectomy

1 ho had carotid artery stenting, 1105 who had carotid endarterectomy).

2 haracteristics and outcome in men undergoing carotid endarterectomy.

3 MI and biomarker+ only were more common with carotid endarterectomy.

4 immunohistochemistry for patients undergoing carotid endarterectomy.

5 fell for coronary-artery bypass grafting and carotid endarterectomy.

6 her risk of myocardial infarction (MI) after carotid endarterectomy.

7 ratio to receive carotid artery stenting or carotid endarterectomy.

8 fety of carotid artery stenting with that of carotid endarterectomy.

9 oke would improve the risk-benefit ratio for carotid endarterectomy.

10 tid-artery stenting and the group undergoing carotid endarterectomy.

11 enosis to undergo carotid-artery stenting or carotid endarterectomy.

12 es were obtained from patients who underwent carotid endarterectomy.

13 y, coronary artery bypass graft surgery, and carotid endarterectomy.

14 eems to be similar to timing of stroke after carotid endarterectomy.

15 suggest that outcomes may approach those of carotid endarterectomy.

16 rd deviation]) who were scheduled to undergo carotid endarterectomy.

17 event within the previous 5 days) undergoing carotid endarterectomy.

18 mesenteric and renal revascularization, and carotid endarterectomy.

19 emboli-protection device is not inferior to carotid endarterectomy.

20 were collected from 159 patients undergoing carotid endarterectomy.

21 nvolved in cerebral hyperperfusion following carotid endarterectomy.

22 omised controlled trial of patients awaiting carotid endarterectomy.

23 Stent Trial comparing carotid stenting with carotid endarterectomy.

24 dural complication rates similar to those of carotid endarterectomy.

25 giography in most patients examined prior to carotid endarterectomy.

26 nt has emerged as a potential alternative to carotid endarterectomy.

27 lective infrarenal aortic reconstruction and carotid endarterectomy.

28 sus adjacent media of 13 patients undergoing carotid endarterectomy.

29 70-99% carotid stenosis may not benefit from carotid endarterectomy.

30 d arteries in a group of patients undergoing carotid endarterectomy.

31 g/kg, n = 7) before undergoing microsurgical carotid endarterectomy.

32 in healthy controls and patients undergoing carotid endarterectomy.

33 betic and 30 nondiabetic patients undergoing carotid endarterectomy.

34 artery stenosis most likely to benefit from carotid endarterectomy.

35 netic resonance imaging, 46.9% (n=15) before carotid endarterectomy.

36 tic plaques removed from patients undergoing carotid endarterectomy.

37 ed with swelling in his left neck after left carotid endarterectomy.

38 oke after carotid artery stenting than after carotid endarterectomy.

39 treated with carotid artery stenting versus carotid endarterectomy.

40 ocated to receive carotid artery stenting or carotid endarterectomy.

41 llation, and absence of previous ipsilateral carotid endarterectomy.

42 nly after carotid artery stenting than after carotid endarterectomy.

43 s, ranging from a relative decline of 8% for carotid endarterectomy (1.3% mortality in 1999 and 1.2%

44 g compared with 16 (3.8%) of 417 assigned to carotid endarterectomy (1.84, 1.01-3.37; interaction p=0

45 nt vs. 3.8 percent) to only 0.2 percent (for carotid endarterectomy, 1.7 percent vs. 1.5 percent).

46 dicted an increased rate of restenosis after carotid endarterectomy (2.26, 1.34-3.77) but not after c

47 ting (Kaplan-Meier rate 6.0%) and 62 who had carotid endarterectomy (6.3%) had restenosis or occlusio

48 common procedures were herniorrhaphy (10%), carotid endarterectomy (6.6%), and open colectomy (5.6%)

49 Of 366 patients with carotid endarterectomy, 61 exhibited some degree of LOY

50 Of the treated vessels, 59 (22%) had prior carotid endarterectomy, 66 (24%) had ulcerated plaques,

51 ion to stroke or death in patients receiving carotid endarterectomy, a harm of screening included the

52 domly assigned to carotid artery stenting or carotid endarterectomy (Abbott Vascular).

53 Before carotid endarterectomy, all patients underwent positron

54 with high-grade stenosis derive benefit from carotid endarterectomy, although they have different ris

55 Almost half (47.5%) of the carotid endarterectomies among Ohio's Medicare populatio

56 grated with gene expression profiling of 121 carotid endarterectomies and an analysis of protein secr

57 intraoperative monitoring during 709 primary carotid endarterectomies and investigated the impact of

58 rosclerotic lesions from each of 13 cases of carotid endarterectomy and 16 lower limb amputations and

59 ients with culprit carotid stenosis awaiting carotid endarterectomy and 8 controls without culprit ca

60 Carotid endarterectomy and carotid artery stenting are t

61 disease burden in women, review outcomes of carotid endarterectomy and carotid artery stenting in wo

62 Carotid endarterectomy and carotid artery stenting.

63 t and rates were similar up to 2 years after carotid endarterectomy and carotid artery stenting.

64 well as that of an intraoperative monitor in carotid endarterectomy and carotid stenting.

65 The potential for expanded indications for carotid endarterectomy and development of percutaneous t

66 monocytes purified from patients undergoing carotid endarterectomy and normal subjects by using the

67 Human plaques were derived from carotid endarterectomy and stained against P2X7.

68 tional trends in performance and outcomes of carotid endarterectomy and stenting among Medicare benef

69 mpared included immediate revascularization (carotid endarterectomy) and ongoing medical therapy (wit

70 going open abdominal aortic aneurysm repair, carotid endarterectomies, and peripheral vascular operat

71 rction, revascularization procedure, stroke, carotid endarterectomy, and amputation in CHOICE; and as

72 ry disease are optimizing medical treatment, carotid endarterectomy, and carotid artery stenting.

73 on, anesthetic technique, and monitoring for carotid endarterectomy, and durability of stenting and a

74 t that carotid stenting may be comparable to carotid endarterectomy, and it underscores the clinical

75 ous comorbid conditions are at high risk for carotid endarterectomy, and may be safely treated by car

76 These signals are particularly common after carotid endarterectomy, and this provides a situation in

77 We examined rates of CABG, carotid endarterectomy, and total hip replacement in 158

78 res: coronary-artery bypass grafting (CABG), carotid endarterectomy, and total hip replacement.

79 ssion medications on all patients undergoing carotid endarterectomy, aortic surgery, or lower extremi

80 grafting, abdominal aortic aneurysm repair, carotid endarterectomy, aortic valve replacement, esopha

81 Carotid-artery stenting and carotid endarterectomy are both options for treating car

82 Carotid endarterectomy can be safely performed in a comm

83 The rates of carotid endarterectomy, cardiac catheterization, coronar

84 carotid stenosis and high-risk features for carotid endarterectomy, carotid artery stenting with dis

85 From a series of 886 primary carotid endarterectomy cases, SP and mean arterial press

86 ACAS) showed significant risk reductions for carotid endarterectomy (CE) but did not consider the cos

87 Carotid endarterectomy (CE) has been shown to be more ef

88 of carotid artery stenting (CAS) relative to carotid endarterectomy (CEA) among Medicare patients has

89 me and the risk of stroke or death following carotid endarterectomy (CEA) and carotid artery stenting

90 -day readmission between patients undergoing carotid endarterectomy (CEA) and carotid artery stenting

91 In patients with carotid artery disease, carotid endarterectomy (CEA) and carotid stenting (CAS)

92 roke affects 2% to 3% of patients undergoing carotid endarterectomy (CEA) and is preceded by 1 to 2 h

93 procedural ischemic DWI lesions after CAS or carotid endarterectomy (CEA) are associated with an incr

94 The outcome of standard longitudinal carotid endarterectomy (CEA) can be measured by preserva

95 rk trials excluding dialysis patients showed carotid endarterectomy (CEA) decreased stroke risk compa

96 Staged carotid endarterectomy (CEA) followed by OHS or combined

97 ative stroke is a persistent complication of carotid endarterectomy (CEA) for patients with symptomat

98 abdominal aortic aneurysm (AAA) repair, and carotid endarterectomy (CEA) from 1998 to 2001 using the

99 Recurrent stenosis after carotid endarterectomy (CEA) has been reported to vary b

100 Carotid endarterectomy (CEA) has been shown to be more e

101 Carotid endarterectomy (CEA) has clearly been shown to b

102 ioplasty and stenting (CAS) is equivalent to carotid endarterectomy (CEA) in patients with symptomati

103 is Study (ACAS) demonstrated the efficacy of carotid endarterectomy (CEA) in reducing the risk of str

104 d Atherosclerosis Study (ACAS) reported that carotid endarterectomy (CEA) is beneficial for patients

105 Carotid endarterectomy (CEA) is still considered the gol

106 Carotid endarterectomy (CEA) is supported by level 1 evi

107 Although carotid endarterectomy (CEA) is the established gold sta

108 of asymptomatic carotid artery stenosis with carotid endarterectomy (CEA) or carotid angioplasty and

109 alent risk of major adverse events following carotid endarterectomy (CEA) or carotid artery stenting

110 Given the controversy regarding whether carotid endarterectomy (CEA) or carotid artery stenting

111 dentify articles comparing early outcomes of carotid endarterectomy (CEA) or carotid stenting (CAS) i

112 Carotid revascularization with carotid endarterectomy (CEA) or stenting (CAS) is freque

113 The benefit of carotid endarterectomy (CEA) over medical therapy in pat

114 invasive alternative for high-risk surgical carotid endarterectomy (CEA) patients.

115 n abdominal aortic aneurysm repair (OAR) and carotid endarterectomy (CEA) performed by very low-volum

116 omparative studies of medical therapy alone, carotid endarterectomy (CEA) plus medical therapy, or ca

117 or other neurological symptoms), successful carotid endarterectomy (CEA) reduces stroke incidence fo

118 It is generally accepted that carotid endarterectomy (CEA) reduces the risk of stroke

119 ate can be administered at the conclusion of carotid endarterectomy (CEA) to reverse the anticoagulan

120 f surgical risks and long-term benefits from carotid endarterectomy (CEA) was unclear.

121 al demonstrated that CAS was not inferior to carotid endarterectomy (CEA) when performed by physician

122 g (CAS) has achieved clinical equipoise with carotid endarterectomy (CEA), as evidenced by 2 large U.

123 tomy, vascular infrainguinal reconstruction, carotid endarterectomy (CEA), lung lobectomy/pneumonecto

124 comparing carotid artery stenting (CAS) and carotid endarterectomy (CEA), with better CEA outcomes t

125 ndrome (CHS) is an important complication of carotid endarterectomy (CEA), yet prior research has bee

126 ed with carotid artery stenting (CAS) versus carotid endarterectomy (CEA).

127 ported after carotid artery stenting CAS and carotid endarterectomy (CEA).

128 ation in patients who subsequently underwent carotid endarterectomy (CEA).

129 oing carotid duplex imaging before and after carotid endarterectomy (CEA).

130 of patients with carotid artery stenosis for carotid endarterectomy (CEA).

131 abdominal aortic aneurysm [AAA] repairs, 100 carotid endarterectomies [CEA], and 7 esophagectomies an

132 ntly referred for carotid revascularization (carotid endarterectomy [CEA] or CS) based on the results

133 At present, carotid endarterectomy combined with optimal drug therap

134 Risks of stroke and complications from carotid endarterectomy, costs, and quality of life value

135 e Medicare beneficiaries, the performance of carotid endarterectomy declined from 1999 to 2014, where

136 es (n=10) collected from patients undergoing carotid endarterectomy demonstrated that subsets of lipi

137 ysm repair, coronary artery bypass grafting, carotid endarterectomy, esophageal cancer resection, hip

138 challenges presented by patients undergoing carotid endarterectomy, excellent outcomes have been ach

139 In this time of evidence-based medicine, carotid endarterectomy fares badly, with only the indica

140 urified these cells from patients undergoing carotid endarterectomy for advanced atherosclerosis and

141 th or without stenting) is an alternative to carotid endarterectomy for carotid artery stenosis but t

142 th duplex ultrasonography and treatment with carotid endarterectomy for CAS.

143 hy, and the intervention in the 3 trials was carotid endarterectomy for patients with stenosis exceed

144 on and specific risk factors; and performing carotid endarterectomy for patients with stenosis of at

145 Carotid endarterectomy for stroke prevention has been th

146 Stents are an alternative treatment to carotid endarterectomy for symptomatic carotid stenosis,

147 t differ between carotid artery stenting and carotid endarterectomy for symptomatic or asymptomatic c

148 of recent data indicates a clear benefit of carotid endarterectomy for symptomatic patients with hig

149 emboli-protection device is not inferior to carotid endarterectomy for the treatment of carotid arte

150 a less invasive percutaneous procedure than carotid endarterectomy for the treatment of carotid sten

151 tor (GIPR) and OPN mRNA levels are higher in carotid endarterectomies from patients with symptoms (st

152 allocated to carotid artery stenting, 500 to carotid endarterectomy) had baseline imaging available.

153 platelet therapy, anticoagulant therapy, and carotid endarterectomy have all proven to be effective i

154 red in carotid artery stenting and 28 MIs in carotid endarterectomy (hazard ratio, 0.50; 95% confiden

155 of mortality were smoking history, previous carotid endarterectomy, hemoglobin level, and increasing

156 g compared with 40 (4.9%) of 823 assigned to carotid endarterectomy (HR 0.90, 95% CI 0.57-1.41) and 3

157 similar association in patients treated with carotid endarterectomy (HR for any stroke 1.18, 0.40-3.5

158 teral middle cerebral artery were made after carotid endarterectomy in 12 control patients and 12 pat

159 ith IPH on MR images would undergo immediate carotid endarterectomy in addition to ongoing intensive

160 cruiting patients to compare CAS with EFD to carotid endarterectomy in different cohorts, such as pat

161 The effect of carotid endarterectomy in lowering the risk of stroke ip

162 is designed to look back over the history of carotid endarterectomy in order to understand the evolut

163 -artery stenting with embolic protection and carotid endarterectomy in patients 79 years of age or yo

164 protection") is an effective alternative to carotid endarterectomy in patients at average or high ri

165 The effect of carotid endarterectomy in patients who present with tran

166 d with a higher risk of stroke compared with carotid endarterectomy in patients with an ARWMC score o

167 s, but might be an acceptable alternative to carotid endarterectomy in patients with less extensive l

168 The authors determined whether carotid endarterectomy in patients with recurrent stenos

169 t differ between carotid artery stenting and carotid endarterectomy in patients with symptomatic and

170 may resolve the role of carotid stenting and carotid endarterectomy in primary and secondary stroke p

171 rotic plaques of patients undergoing primary carotid endarterectomy in the province of Utrecht from 2

172 has proven to be a potential alternative to carotid endarterectomy in the treatment of severe caroti

173 Carotid endarterectomy is associated with similar neurol

174 Carotid endarterectomy is more effective than medical ma

175 Carotid endarterectomy is now celebrating its 50th anniv

176 es where the balance of risk and benefit for carotid endarterectomy is particularly narrow, and to ex

177 While trials have demonstrated that carotid endarterectomy is superior to best medical thera

178 ing asymptomatic patients and treatment with carotid endarterectomy is unknown; the benefit is limite

179 Carotid artery stenting, compared with carotid endarterectomy, is emerging as an effective and

180 lerotic lesions from specimens obtained from carotid endarterectomies, lower limb amputations, and th

181 r elective abdominal aortic aneurysm repair, carotid endarterectomy, lower extremity arterial bypass

182 Carotid endarterectomy lowers the risk of carotid territ

183 patients with transient monocular blindness, carotid endarterectomy may be beneficial when other risk

184 the study, 937111 unique patients underwent carotid endarterectomy (mean age, 75.8 years; 43% women)

185 oke rates in patients without symptoms after carotid endarterectomy, medical therapy of asymptomatic

186 008, 2502 patients were randomly assigned to carotid endarterectomy (n=1240) or carotid artery stenti

187 uce restenosis after coronary angioplasty or carotid endarterectomy, nor does it prevent a first stro

188 the medical therapy-only group could undergo carotid endarterectomy only with substantial carotid art

189 arization, lower-extremity arterial disease, carotid endarterectomy or angioplasty, or abdominal aort

190 s) with the odds of procedural intervention (carotid endarterectomy or carotid artery stenting) compa

191 that was deemed equally suitable for either carotid endarterectomy or endovascular treatment were ra

192 cal practice, decision making with regard to carotid endarterectomy or stenting is still primarily ba

193 grafting (OR, 1.17; 95% CI, 1.05-1.29), and carotid endarterectomy (OR, 1.21; 95% CI, 1.04-1.40).

194 artery bypass surgery, coronary angioplasty, carotid endarterectomy, other cancer surgery, and orthop

195 ECST trials demonstrated the superiority of carotid endarterectomy over medical therapy in the preve

196 ), more invasive surgery (surgery other than carotid endarterectomy, p = 0.02), and impaired brachial

197 68.2%, P = 0.03); the effect was greatest in carotid endarterectomy patients (RB = 73.4% vs. no RB =

198 additional 8 carotid artery stenting and 12 carotid endarterectomy patients had biomarker+ only (haz

199 revascularization, cerebrovascular accident, carotid endarterectomy, peripheral revascularization, ga

200 Carotid endarterectomy presents a risk of myocardial inf

201 isolated coronary artery bypass grafting or carotid endarterectomy procedures performed for disease

202 Patients presenting for carotid endarterectomy provide anesthesiologists with ma

203 placement, abdominal aortic aneurysm repair, carotid endarterectomy, radical cystectomy, pancreatic r

204 Carotid endarterectomy rate during each month from 1989

205 Does intervention with carotid endarterectomy reduce morbidity or mortality?

206 In a meta-analysis, carotid endarterectomy reduced rates of 1) perioperative

207 Carotid endarterectomy reduces the risk of stroke in pat

208 cutaneous transluminal coronary angioplasty, carotid endarterectomy, reduction of femur fracture, tot

209 Carotid endarterectomy remains the standard of care for

210 Carotid endarterectomy remains the standard of care, eve

211 , including coronary artery bypass grafting, carotid endarterectomy, repair of nonruptured abdominal

212 Does screening or carotid endarterectomy result in harm?

213 d trials comparing filter-protected CAS with carotid endarterectomy revealed a higher periprocedural

214 00 expression in >70 samples obtained during carotid endarterectomy revealed that local miR-100 expre

215 xpressed in human atherosclerotic lesions in carotid endarterectomy samples (n = 18) but were not exp

216 que instability as seen in humans, and human carotid endarterectomy samples.

217 Ig repertoires were analyzed by RT-PCR in carotid endarterectomy samples.

218 and X-Act Stent in patients at high risk for Carotid Endarterectomy [SECuRITY]) have compared favorab

219 In the meantime, carotid endarterectomy should remain the treatment of ch

220 de, atherosclerotic plaques harvested during carotid endarterectomy show a time-dependent change in p

221 tegies among vascular patients scheduled for carotid endarterectomy significantly improved over the p

222 C. pneumoniae from a prospectively obtained carotid endarterectomy specimen.

223 Macrophage content was assessed in all carotid endarterectomy specimens as a percentage of CD68

224 ing agent versus control agent) and in human carotid endarterectomy specimens ex vivo (n=14; P<0.05).

225 Carotid endarterectomy specimens from 16 patients who we

226 lar matrix and associated molecules in human carotid endarterectomy specimens from 6 symptomatic vers

227 )F-NaF uptake was compared with histology in carotid endarterectomy specimens from patients with symp

228 Carotid endarterectomy specimens of 20 patients were inc

229 In human carotid endarterectomy specimens TLR7 levels were consis

230 (rho=0.721, P=0.019) in the 10 corresponding carotid endarterectomy specimens.

231 assessed by immunohistochemical staining of carotid endarterectomy specimens.

232 f SMC subsets in cultures derived from human carotid endarterectomy specimens.

233 llenge the conclusions from the Asymptomatic Carotid Endarterectomy Study and the North American Symp

234 within atherosclerotic tissue at the time of carotid endarterectomy, suggesting that ozone production

235 In human plaques, collected during carotid endarterectomy surgery, we found that 14q32 micr

236 vascular event between 5 and 180 days of the carotid endarterectomy [symptomatic]) confirmed elevatio

237 In human plaques obtained by carotid endarterectomy, TF immunoreactivity (8+/-5% vers

238 Following emergent carotid endarterectomy, the patient's partial third-nerv

239 erative length of stay ranged from 3.4 days (carotid endarterectomy) to 19.6 days (esophagectomy).

240 e trials were the North American Symptomatic Carotid Endarterectomy Trial (NASCET clinical alert rele

241 The North American Symptomatic Carotid Endarterectomy Trial (NASCET) and the Asymptomat

242 The North American Symptomatic Carotid Endarterectomy Trial (NASCET) and the Asymptomat

243 9%) patients were North American Symptomatic Carotid Endarterectomy Trial (NASCET) eligible.

244 ould have met the North American Symptomatic Carotid Endarterectomy Trial (NASCET) entry criteria.

245 t stenosis by the North American Symptomatic Carotid Endarterectomy Trial (NASCET) method.

246 s measured by the North American Symptomatic Carotid Endarterectomy Trial (NASCET).

247 inclusion in the North American Symptomatic Carotid Endarterectomy Trial (NASCET).

248 omy Study and the North American Symptomatic Carotid Endarterectomy Trial regarding the benefits of C

249 ery Trial (ECST), North American Symptomatic Carotid Endarterectomy Trial, and Veterans Affairs trial

250 Surgery Trial and North American Symptomatic Carotid Endarterectomy Trial.

251 on data from the North American Symptomatic Carotid Endarterectomy Trial.

252 mmense amount of data generated by the major carotid endarterectomy trials are defining particular su

253 Twenty patients scheduled for carotid endarterectomy underwent 3.0-T carotid MR imagin

254 Eighteen patients scheduled for carotid endarterectomy underwent a preoperative carotid

255 Twenty-two subjects who were scheduled for carotid endarterectomy underwent MRI with a 3-dimensiona

256 Fourteen patients scheduled for carotid endarterectomy underwent preoperative carotid MR

257 Thirty-four patients undergoing carotid endarterectomy underwent screening of carotid at

258 Thirty-day stroke and death rates from carotid endarterectomy vary from 2.7% to 4.7% in RCTs; h

259 In patients randomized to carotid endarterectomy versus carotid artery stenting, b

260 The RCTs of carotid endarterectomy versus medical treatment were con

261 trials (RCTs) of screening for CAS; RCTs of carotid endarterectomy versus medical treatment; systema

262 tid Atherosclerosis Study (ACAS) showed that carotid endarterectomy was beneficial for symptom-free p

263 carotid stenosis and high-risk features for carotid endarterectomy was conducted between April 2004

264 disease was confirmed by angiography before carotid endarterectomy was done.

265 Carotid endarterectomy was performed in 9,219 (94%) whit

266 METHODS AND Carotid endarterectomies were obtained from patients wit

267 ty-six laparoscopic cholecystectomies and 22 carotid endarterectomies were studied using direct obser

268 nt for carotid artery stenting compared with carotid endarterectomy were 6.2% versus 6.8% in men (haz

269 pothesis, 50 human specimens obtained during carotid endarterectomy were examined for the presence of

270 Twenty-six patients scheduled for carotid endarterectomy were imaged with a 1.5-T GE scann

271 (mean age 70 years; 54 males) scheduled for carotid endarterectomy were imaged with a 1.5-T scanner

272 Twenty-one patients scheduled for carotid endarterectomy were imaged with a 1.5-T scanner.

273 0% carotid artery stenosis and who underwent carotid endarterectomy were included in the study.

274 (mean age, 71 years; 49 male) scheduled for carotid endarterectomy were recruited after obtaining in

275 n; mean age +/- SD, 68.3 +/- 7.3) undergoing carotid endarterectomy were recruited for combined carot

276 tal of 20 consecutive patients scheduled for carotid endarterectomy were recruited to participate in

277 sts; and observational studies of harms from carotid endarterectomy were selected to answer the follo

278 attack, stroke, or amaurosis fugax), due for carotid endarterectomy, were prospectively recruited.

279 attack, stroke, or amaurosis fugax), due for carotid endarterectomy, were prospectively recruited.

280 of carotid artery stenting (CAS) relative to carotid endarterectomy when performed by physicians with

281 carotid artery stenting than those who have carotid endarterectomy whereas there is little differenc

282 carotid artery stenting (CAS) compared with carotid endarterectomy, which may differ in specific pat

283 ummarize the randomized trial data comparing carotid endarterectomy with carotid artery stenting and

284 omatic Subjects Who Are at Standard Risk for Carotid Endarterectomy With Significant Extracranial Car

285 Carotid endarterectomy without another concurrent surger

286 pothesis that high-risk patients can undergo carotid endarterectomy without associated increased risk